Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.ijid.2021.05.050 http://scihub22266oqcxt.onion/10.1016/j.ijid.2021.05.050 34044140!8142712!34044140     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=34044140&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Int+J+Infect+Dis 2021 ; 108 (ä): 209-211 Nephropedia Template TP {{tp|p=34044140|t=2021. Multisystem inflammatory syndrome in adults: A rare sequela of SARS-CoV-2 infection |pdf=|usr=}}{{34044140}} gab.com Text Multisystem inflammatory syndrome in adults: A rare sequela of SARS-CoV-2 infection JO: Int J Infect Dis http://www.kidney.de/pget.php?&tw=1&pmid=34044140 #FOAvip Multisystem inflammatory syndrome in adults (MIS-A) came to attention back in June 2020, when the United States Center for Disease Control and Prevention (CDC) received initial reports regarding patients who had presented delayed and multisystem involvement of the disease, with clinical course resembling multisystem inflammatory syndrome in children (MIS-C). This study introduces a case of MIS-A, where the patient presented 3 weeks after initial COVID-19 exposure. His clinical course was consistent with the working definition of MIS-A as specified by the CDC. Aggressive supportive care in the intensive care unit, utilization of advanced heart failure devices, and immunomodulatory therapeutics (high-dose steroids, anakinra, intravenous immunoglobulin) led to clinical recovery. Management of MIS-A is a topic of ongoing research and needs more studies to elaborate on treatment modalities and clinical predictors. Twit Text FOAVip Multisystem inflammatory syndrome in adults: A rare sequela of SARS-CoV-2 infection ????Int J Infect Dis http://www.kidney.de/pget.php?&tw=1&pmid=34044140 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34044140 #FOAvip English Wikipedia <ref>{{Cite pmid|34044140}}</ref> Multisystem inflammatory syndrome in adults: A rare sequela of SARS-CoV-2 infection #MMPMID34044140 Ahmad F; Ahmed A; Rajendraprasad SS; Loranger A; Gupta S; Velagapudi M; Vivekanandan R; Nahas JA; Plambeck R; Moore D Int J Infect Dis 2021[Jul]; 108 (ä): 209-211 PMID34044140show ga Multisystem inflammatory syndrome in adults (MIS-A) came to attention back in June 2020, when the United States Center for Disease Control and Prevention (CDC) received initial reports regarding patients who had presented delayed and multisystem involvement of the disease, with clinical course resembling multisystem inflammatory syndrome in children (MIS-C). This study introduces a case of MIS-A, where the patient presented 3 weeks after initial COVID-19 exposure. His clinical course was consistent with the working definition of MIS-A as specified by the CDC. Aggressive supportive care in the intensive care unit, utilization of advanced heart failure devices, and immunomodulatory therapeutics (high-dose steroids, anakinra, intravenous immunoglobulin) led to clinical recovery. Management of MIS-A is a topic of ongoing research and needs more studies to elaborate on treatment modalities and clinical predictors. |*COVID-19[MESH] |Adult[MESH] |Child[MESH] |Humans[MESH] |Immunoglobulins, Intravenous/therapeutic use[MESH] |Interleukin 1 Receptor Antagonist Protein/therapeutic use[MESH] |SARS-CoV-2[MESH] |Systemic Inflammatory Response Syndrome[MESH]Multisystem inflammatory syndrome in adults: A rare sequela of SARS-Co(epmc).pdf DeepDyve Pubget Overpricing